Patent details
91435 Product Name: "Combinaison comprenant de la vildagliptine ou un de ses sels pharmaceutiquement acceptable et de la metformine ou un de ses sels pharmaceutiquement acceptable (EUCREAS®)"
Basic Information
- Publication number:
- 91435
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP999593965
- Legal Status:
- Lapsed
- Application number:
- 91435
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/07/425/001-018 - EUCREAS-vildagliptin
- Marketing Authorization Type:
- Marketing Authorization Date:
- 14/11/2007
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 09/05/2008
- First Marketing Authorization date:
- 14/11/2007
- Grant date:
- 09/07/2008
- Activation date:
- 09/12/2019
- Publication date:
- 09/07/2008
- Lapsed date:
- Expiration date:
- Renunciation date:
- 14/11/2012
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 14/11/2022
- SPC Extension Expiration:
- 14/11/2022
- Rejection date:
- Withdrawal date:
Owner
- From:
- 09/05/2008
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 09/05/2008
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- VILLHAUER Edwin, Bernard
- Address:
- United States (US)
| Filing date | Document type | Number of pages |
|---|